Clinical Trials

NCT06868849 | RECRUITING | PHASE1/PHASE2
307 participants

A Study of JMT203 in Patients With Cancer Cachexia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2024-05-15
Completion:
2027-08-14
Conditions
  • Non Small Cell Lung Cancer
  • Pancreatic Cancer
  • Cancer Cachexia
  • Colorectal Cancer Cachexia
  • Pancreatic Cancer Cachexia
Interventions
  • DRUG
No Results Yet
NCT06861309 | RECRUITING | NA
60 participants

Placental Imaging Techniques

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-04-23
Completion:
2026-07-31
Conditions
  • Fetal Growth Restriction (FGR)
  • Placental Insufficiency
  • Preeclampsia
  • Still Births
  • Pregnancy
  • Pregnancy Complications
  • Pregnancy Outcomes
  • Ultrasound
Interventions
  • DEVICE
No Results Yet
NCT06843967 | RECRUITING | PHASE1/PHASE2
54 participants

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-02-19
Completion:
2028-08-19
Conditions
  • Well Differentiated Liposarcoma
  • Dedifferentiated Liposarcoma
  • Liposarcoma
  • Myxoid Liposarcoma
  • Round Cell Liposarcoma
  • Myxoid Pleomorphic Liposarcoma
  • Pleomorphic Liposarcoma
  • Unresectable Liposarcoma
  • Unresectable Dedifferentiated Liposarcoma
Interventions
  • DRUG
No Results Yet
NCT06813664 | NOT_YET_RECRUITING | PHASE2
60 participants

ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2026-06-01
Completion:
2028-04-01
Conditions
  • Metastatic NSCLC - Non-Small Cell Lung Cancer
  • OligoProgressive Metastatic Disease
Interventions
  • RADIATION
No Results Yet
NCT06795893 | RECRUITING
240 participants

The Anifrolumab PRIM Program

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-22
Start Date:
2025-11-07
Completion:
2031-04-15
Conditions
  • Systemic Lupus Erythematosus
Interventions
  • DRUG
No Results Yet
NCT06789172 | RECRUITING | PHASE1
166 participants

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2025-01-23
Completion:
2028-07-31
Conditions
  • Solid Tumours
  • Sarcoma
  • HNSCC
  • Non Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • NSCLC
  • Pancreatic Adenocarcinoma
  • Colorectal Cancer (CRC)
  • Myxofibrosarcoma (MFS)
  • Solitary Fibrous Tumors
  • Dedifferentiated Liposarcoma
  • Undifferentiated Pleomorphic Sarcoma (UPS)
Interventions
  • DRUG
  • COMBINATION_PRODUCT
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page